Viral Sensitizers Market

The viral sensitizers market consists of compounds that improve the effectiveness of antiviral treatments and vaccines by making viruses more vulnerable. Key customers include pharmaceutical companies, biotechnology firms, and research institutes. Growth is primarily driven by rising demand in oncology and infectious disease treatment, advancements in immunotherapy, and an increasing global prevalence of cancer.